Work

A phase II trial of temsirolimus plus low-dose weekly carboplatin and paclitaxel for recurrent/metastatic HNSCC.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.6019

Authors: Matthew G. Fury, Han Xiao, Shrujal S. Baxi, Eric Jeffrey Sherman, Stephanie Smith-Marrone, Alan Loh Ho, Camelia S. Sima, Obiageli Ginka Nwankwo, Sofia Haque, Nora Katabi, David G. Pfister

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2731136968

Cites:

Cited by: 8

Related to: 10